bharatbook | 5 hours ago
Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant
PR News Wire (Free subscription) | yesterday
MIDLAND, Mich., Nov. 20 /PRNewswire-FirstCall/ -- Dow Corning Corp. today opened a Solar Solutions Application & Business Center in Newark, California that will serve as its West Coast hub for customer sales, product evaluation and the development of commercialization strategy.
PR News Wire (Free subscription) | yesterday
COVINGTON, Ky., Nov. 20 /PRNewswire-FirstCall/ -- Lamar M. Chambers, senior vice president and chief financial officer of Ashland Inc. (NYSE: ASH), will make a presentation at the Bank of America Merrill Lynch 2009 Credit Conference in New York City on Wednesday, Dec. 2, 2009, at 11:50 a.m. EST. In his remarks, Chambers will review Ashland's businesses, strategies and priorities.
The Sloman Economics News Site (Free subscription) | yesterday
The National Institute for Health and Clinical Excellence (NICE) is the independent agency in the UK charged, amongst other things, with assessing the cost-effectiveness of new drugs. In a report published on 19 November 2009, NICE found that the drug sorafenib, branded as Nexavar by its manufacturer, the German pharmaceutical company, Bayer AG, was [...]
Market Wire (Free subscription) | yesterday
BATON ROUGE, LA (MARKET WIRE) Written by John Egan for Industrial Info Resources (Sugar Land, Texas) -- The U.S. Chemical Processing Industry (CPI) is projected to increase spending for capital projects and maintenance turnarounds in 2010, according to Trey Hamblet, Industrial Info's vice president of research for the Chemical Processing Industry. "This year has been incredibly difficult, but...
PharmaGossip (Free subscription) | 11/20/2009
Justice Department Recovers $2.4 Billion in False Claims Cases in Fiscal Year 2009; More Than $24 Billion Since 1986 FY09 Recovery is Second Largest in History WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- The United States secured $2.4 billion in settlements and judgments in cases involving fraud against the government in the fiscal year ending Sept. 30, 2009, the Justice Department announced today....
Business Wire (Free subscription) | 11/20/2009
NEW YORK--(BUSINESS WIRE)--Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Mae Walker today filed a personal injury lawsuit against Bayer Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by Bayer’s birth control drug Yaz. Walker’s complaint charges that Yaz is a dangerous prescription drug sold...
All Africa (Free subscription) | 11/19/2009
THE legal action instituted against Bayer CropScience AG by farmers in the United States for allegedly contaminating their farms with Genetically Modified (GM) rice seeds in 2006 is a further confirmation of the validity of tests carried out on rice samples collected by the Environmental Rights Action/Friends of the Earth Nigeria (ERA/FoEN) in Nigeria and other West African countries within the same...
Market Wire (Free subscription) | 11/19/2009
RENO, NV (MARKET WIRE) Altair Nanotechnologies, Inc. (Altairnano) (NASDAQ: ALTI), a leading provider of energy storage systems for clean, efficient power and energy management, today announced the resignation of Robert F. Hemphill from Altairnano's Board of Directors, a position he has held since May, 2007.
Business Wire (Free subscription) | 11/19/2009
DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a leading, global chemical company, today announced that Mark Oberle, vice president, investor relations and public affairs, and Chris Jensen, vice president and corporate controller, will address investors at the Bank of America Merrill Lynch 2009 Credit Conference in New York on Wednesday, December 2, 2009, at 3:20 p.m. Eastern time. A webcast...
Fiercebiotech (Free subscription) | 11/19/2009
Bayer HealthCare and Johnson & Johnson have good news to present about their blood-thinner Xarelto--a potential blockbuster that the FDA declined to approve months ago. Results from a long-term clinical trial showed taking Xarelto led to an 82 percent lower risk that a venous blood clot would form again compared with placebo, according to a Reuters article. The Phase III EINSTEIN-extension study...
PR News Wire (Free subscription) | 11/19/2009
CLEVELAND, Nov. 19 /PRNewswire/ -- Resilience Capital Partners (www.resiliencecapital.com), a Cleveland-based private equity firm, has added Mr. Steven J. Demetriou as a member of its Executive Committee and its Board of Advisors. Steven J. Demetriou, since December 2004 has been the Chairman of the Board and Chief Executive Officer of Aleris International, Inc., an international aluminum company,...
PR News Wire (Free subscription) | 11/19/2009
HOUSTON, Nov. 19 /PRNewswire/ -- On March 23-25, 2010, Chemical Market Associates, Inc. (CMAI) will host its 25th Annual World Petrochemical Conference and Workshops in Houston, Texas at the Hilton Americas Hotel. This annual event boasts over 35 industry experts as speakers, consisting of respected industry leaders from companies all over the world complemented by CMAI product experts from its global...
SPICY IP (Free subscription) | 11/19/2009
Thanks to Sumathi's wizadry over Google we have for your viewing pleasure yet another Order authored by Justice Murlidhar on two very crucial provisions of the Patents Act – Section 8 & Section 47 (In this post I'll cover only the Section 8 aspect, the Section 47 aspect will be covered in a subsequent post – for now let it suffice to say that the patentee lost the case on both sections)....
PR News Wire (Free subscription) | 11/19/2009
SIOUX FALLS, S.D., Nov. 19 /PRNewswire-FirstCall/ -- Raven Industries, Inc. (Nasdaq: RAVN) today reported that its financial results for the three months and nine months ended October 31, 2009, showed continuing profit margin improvement despite weak economic conditions. Sales and net income were down from the previous year's record third quarter, but profit margins reflected productivity gains and...
The 3 latest articles published by users on Chemicals :
bharatbook | 5 hours ago
Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant
aarkstore | 11/13/2009
Summary NOVA Chemicals Corporation (Nova) is a plastics manufacturing company in Canada. The company is principally engaged in manufacturing of plastics, polymers and chemicals. It also produces products through its 50% interest in INEOS NOVA. The product portfolio of the company includes Ethylene, Polyethylene, ARCEL and DYLARK resins, EPS-based Business Ventures, North American EPS, Styrene Equity...
aarkstore | 11/13/2009
Summary Celanese Corporation (Celanese) is a US based leading chemical company. The company is engaged in the manufacturing of integrated chemicals and advanced materials. It is the one of the world’s largest producer of acetyl products and high performance engineered polymers. Celanese operates through four reportable segments namely Acetyl Intermediates, Advanced Engineered Materials, Consumer Specialties...
Videos